Advertisement

Correction to: Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study

  • Yusef MoullaEmail author
  • Tanja Gradistanac
  • Christian Wittekind
  • Uwe Eichfeld
  • Ines Gockel
  • Arne Dietrich
Open Access
Correction

Correction to: J Cardiothorac Surg

https://doi.org/10.1186/s13019-019-0831-0

The original article [1] contains slight errors whereby several terms in the first column of Tables 1, 2, and 3 have an erroneous ‘p’ preceding them. The correct presentation of these tables can be viewed ahead.
Table 1

Main characteristics of the patients, pTNM-Classification 2017, 8th Edition

Characteristics

Number of Patients (n)

Percentage

Tumor-localization

 central

53

26.2%

 peripheral

149

73.8%

Histology

 adenocarcinoma

117

57.4%

 SCCa

75

36.8%

 others

12

5.9%

Grading

In situ

2

1%

 G1

25

12.4%

 G2

95

47.0%

 G3

68

33.3%

 G4

12

5.9%

pT-category

pTis

2

1%

pT1

90

45.1%

 pT1a

10

4.9%

 pT1b

37

18.1%

 pT1c

43

21.1%

pT2

44

26.5

 pT2a

39

19.1%

 pT2b

15

7.4%

pT3

35

17.2%

pT4

23

11.3

pN-category

 pN0

126

61.8%

 pN1

33

16.2%

 pN2

45

22%

pM-category

 pM0

193

94.5%

 pM1a

5

2.5%

 pM1b

5

2.5%

 pM1c

1

0.5%

 L-Status

  

 L0

57

28.1%

 L1

146

71.9%

 V-Status

  

 V0

165

81.3%

 V1

38

18.7%

aSCC Squamous cell carcinoma

Table 2

Univariate Analysis of positive pulmonary and mediastinal lymph nodes (pN1+, pN2+)

Variables

pN1- (%)

pN1+ (%)

P-Value

pN2- (%)

pN2+ (%)

P-Value

Sex

0.148

 

0.627

 male

90 (63.4)

52 (36.6)

112 (78.9)

30 (21.1)

 female

46 (74.2)

16 (25.8)

47 (75.8)

15 (24.2)

Age

0.298

 

0.237

 ≤ 68 years

68 (63)

40 (37)

88 (81.5)

20 (81.5)

 > 68 years

68 (70.8)

28 (29.2)

71 (74.0)

25 (21.2)

Tumor site

0.067

 

0.783

 right

90 (71.4)

36 (28.6)

99 (78.6)

27 (21.4)

 left

46 (59)

32 (41)

60 (76.9)

18 (23.1)

Tumor localization

< 0.001

 

0.02

 central

25 (47.2)

28 (52.8)

36 (66.7)

18 (33.3)

 peripheral

111 (74.5)

38 (25.5)

122 (81.9)

27 (18.1)

Tumor size

0.011

 

0.042

 ≤ 3 cm

77 (75.5)

25 (24.5)

86 (84.3)

16 (15.7)

 > 3 cm

59 (57.8)

43 (42.8)

73 (71.6)

29 (28.4)

Lobe distribution

0.918

 

0.385

 ULa

85 (66.4)

43 (33.6)

97 (75.8)

31 (24.2)

 Non-UL

51 (67.1)

25 (32.9)

62 (81.6)

14 (18.4)

pT-category

0.015

 

0.081

 pT1

70 (77.8)

20 (22.2)

77 (85.6)

13 (14.4)

 pT2

33 (61.1)

21 (38.9)

40 (74.1)

14 (25.9)

 pT3

18 (51.4)

17 (48.6)

23 (65.7)

12 (34.3)

 pT4

13 (56.5)

10 (43.5)

17 (73.9)

6 (26.1)

R-classification

0.017

 

0.088

 R0

130 (68.8)

59 (31.2)

150 (79.4)

39 (20.6)

 R1–2

5 (35.7)

9 (64.3)

8 (57.1)

6 (42.9)

L-status

< 0.001

 

< 0.001

 L0

55 (96.5)

2 (3.5)

56 (98.2)

1 (1.8)

 L1

80 (54.8)

66 (45.2)

102 (69.9)

44 (30.1)

V-status

0.006

 

0.004

 V0

117 (70.9)

48 (29.1)

135 (81.1)

30 (18.2)

 V

18 (47.4)

20 (52.6)

23 (60.5)

15 (39.5)

Pn-Status

0.088

 

0.34

 Pn0

131 (67.9)

62 (32.1)

149 (77.2)

44 (22.8)

 Pn1

4 (40.0)

6 (60.0)

9 (90.0)

1 (10.0)

Histological tumor type

0.214

 

0.646

 Adeno-Ca.b

84 (71.8)

33 (28.2)

94 (80.3)

23 (19.7)

56 (74.4)

19 (25.6)

 SCCc

45 (60.0)

30 (40.0)

9 (75.0)

3 (25.0)

 others

7 (58.3)

5 (41.7)

Grading

0.016

 

0.001

 G1

25 (89.3)

3 (10.7)

27 (96.4)

1 (3.6)

 G2

64 (67.4)

31 (32.6)

79 (83.2)

16 (16.8)

 G3

39 (57.4)

29 (42.6)

43 (63.2)

25 (36.8)

 G4

7 (58.3)

5 (41.7)

9 (75.0)

3 (25.0)

aUL Upper lobe, bAdeno-Ca. Adenocarcinoma, cSCC Squamous cell carcinoma

Table 3

Univariate Analysis of positive lymph nodes (pN0, pN+)

Variables

pN0 (%)

pN+ (%)

P-Value

Sex

0.397

 male

85 (59.9)

57 (40.1)

 female

41 (66.1)

21 (33.9)

Age

0.314

 ≤ 68 years

63 (58.3)

45 (41.7)

 > 68 years

63 (65.6)

33 (34.4)

Tumor site

0.067

 Right

84 (66.7)

42 (33.3)

 Left

42 (53.8)

36 (46.2)

Tumor localization

< 0.001

 central

22 (41.5)

31 (58.5)

 peripheral

104 (69.8)

45 (30.2)

Tumor size

< 0.001

 ≤ 3 cm

76 (74.5)

26 (25.5)

 > 3 cm

50 (49)

52 (51)

Lobe distribution

0.834

 UL a

78 (60.9)

50 (39.1)

 Non-UL

40 (62.5)

24 (37.5)

Number of dissected LN b

0.005

pT-category

0.001

 pT1

69 (76.7)

21 (23.3)

 pT2

27 (50.9)

26 (49.1)

 pT3

17 (47.2)

19 (52.8)

 pT4

11 (47.8)

12 (52.2)

R-classification

0.048

 R0

120 (96.0)

5 (4.0)

 R1–2

69 (88.5)

9 (11.5)

L-status

< 0.001

 L0

54 (94.7)

3 (5.3)

 L1

71 (48.6)

75 (51.4)

V-status

0.001

 V0

111 (67.3)

54 (32.7)

 V1

14 (36.8)

24 (63.2)

Pn-status

0.188

 Pn0

121 (96.8)

4 (3.2)

 Pn1

72 (92.3)

6 (7.7)

Histological tumor type

0.141

 Adeno-Ca.b

79 (67.5)

38 (32.5)

 SCCc

41 (54.7)

34 (45.3)

 others

6 (50.0)

6 (50.0)

Grading

0.005

 G1

22 (88.0)

3 (12.0)

 G2

60 (63.2)

35 (36.8)

 G3

34 (50.0)

34 (50.0)

 G4

6 (50.0)

6 (50.0)

aUL Upper lobe, bAdeno-Ca. Adenocarcinoma, cSCC Squamous cell carcinoma

Reference

  1. 1.
    Moulla Y, et al. Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study. J Cardiothorac Surg. 2019;14:11 https://doi.org/10.1186/s13019-019-0831-0.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Yusef Moulla
    • 1
    Email author
  • Tanja Gradistanac
    • 2
  • Christian Wittekind
    • 2
  • Uwe Eichfeld
    • 1
  • Ines Gockel
    • 1
  • Arne Dietrich
    • 1
  1. 1.Department of Visceral, Transplant, Thoracic and Vascular SurgeryUniversity Hospital of LeipzigLeipzigGermany
  2. 2.Institute of PathologyUniversity Hospital of LeipzigLeipzigGermany

Personalised recommendations